A store-and-forward tele-audiology solution to promote efficient screenings for ototoxicity during cisplatin cancer treatment

Marilyn F. Dille, Garnett P. McMillan, Wendy J. Helt, Dawn Konrad-Martin, Peter Jacobs

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Tele-audiology improves access, controls cost, and improves efficiency ofmany aspects within health care. We have developed and validated a device, the ototoxicity identification device (OtoID), which enables remote hearing monitoring by a patient during chemotherapy treatment. Aspects of the design such as patient self-testing and texting of results to the audiology clinic are important features of this device. Purpose: The purpose of this article is to present the efficacy and effectiveness of the OtoID hearing screener. Research Design: A repeated measures design was used in this study. Study Sample: Twenty-one veterans undergoing cisplatin chemotherapy were recruited in this study. Data Collection and Analysis: Participants were tested using the OtoID at each cisplatin treatment by an audiologist using the manual mode of test and the participant using the automated mode of test. Test sensitivity and specificity were developed from the detection (yes/no) of an American Speech-Language-Hearing Association (ASHA) change in hearing. Results: The OtoID had a test sensitivity of 80.6% and specificity of 85.3%. A logistic regression model analysis of the probability of an ASHA shift identified by the automated OtoID was conducted. Separatemodelswere fit to establish effects of age, average baseline thresholds in the sensitive range for ototoxicity (SRO), and dose of cisplatin on the probability of a positive hearing change result. Interactions were also included to evaluate these effects on the sensitivity and false-positive rates of the automated test. Results indicated no statistically significant effects of age, of baseline hearing in the SRO frequencies, or of cisplatin dose. Conclusions: The OtoID automated test can be recommended for use. The automated test provides significant personnel efficiencies. The modem with simple text messaging function recently added to the device improves on these efficiencies.

Original languageEnglish (US)
Pages (from-to)750-760
Number of pages11
JournalJournal of the American Academy of Audiology
Volume26
Issue number9
DOIs
StatePublished - Oct 1 2015

Fingerprint

Audiology
Cisplatin
Equipment and Supplies
Hearing
Neoplasms
American Speech-Language-Hearing Association
Text Messaging
Therapeutics
Logistic Models
Modems
Drug Therapy
Sensitivity and Specificity
Cost Control
Physiologic Monitoring
Veterans
Research Design
Regression Analysis
Delivery of Health Care

Keywords

  • Chemotherapy
  • Cisplatin
  • OtoID
  • Ototoxicity
  • Tele-audiology
  • Telehealth
  • Veterans

ASJC Scopus subject areas

  • Speech and Hearing

Cite this

A store-and-forward tele-audiology solution to promote efficient screenings for ototoxicity during cisplatin cancer treatment. / Dille, Marilyn F.; McMillan, Garnett P.; Helt, Wendy J.; Konrad-Martin, Dawn; Jacobs, Peter.

In: Journal of the American Academy of Audiology, Vol. 26, No. 9, 01.10.2015, p. 750-760.

Research output: Contribution to journalArticle

Dille, Marilyn F. ; McMillan, Garnett P. ; Helt, Wendy J. ; Konrad-Martin, Dawn ; Jacobs, Peter. / A store-and-forward tele-audiology solution to promote efficient screenings for ototoxicity during cisplatin cancer treatment. In: Journal of the American Academy of Audiology. 2015 ; Vol. 26, No. 9. pp. 750-760.
@article{0ea80ac86d2a40f988942f58bfa33f6c,
title = "A store-and-forward tele-audiology solution to promote efficient screenings for ototoxicity during cisplatin cancer treatment",
abstract = "Background: Tele-audiology improves access, controls cost, and improves efficiency ofmany aspects within health care. We have developed and validated a device, the ototoxicity identification device (OtoID), which enables remote hearing monitoring by a patient during chemotherapy treatment. Aspects of the design such as patient self-testing and texting of results to the audiology clinic are important features of this device. Purpose: The purpose of this article is to present the efficacy and effectiveness of the OtoID hearing screener. Research Design: A repeated measures design was used in this study. Study Sample: Twenty-one veterans undergoing cisplatin chemotherapy were recruited in this study. Data Collection and Analysis: Participants were tested using the OtoID at each cisplatin treatment by an audiologist using the manual mode of test and the participant using the automated mode of test. Test sensitivity and specificity were developed from the detection (yes/no) of an American Speech-Language-Hearing Association (ASHA) change in hearing. Results: The OtoID had a test sensitivity of 80.6{\%} and specificity of 85.3{\%}. A logistic regression model analysis of the probability of an ASHA shift identified by the automated OtoID was conducted. Separatemodelswere fit to establish effects of age, average baseline thresholds in the sensitive range for ototoxicity (SRO), and dose of cisplatin on the probability of a positive hearing change result. Interactions were also included to evaluate these effects on the sensitivity and false-positive rates of the automated test. Results indicated no statistically significant effects of age, of baseline hearing in the SRO frequencies, or of cisplatin dose. Conclusions: The OtoID automated test can be recommended for use. The automated test provides significant personnel efficiencies. The modem with simple text messaging function recently added to the device improves on these efficiencies.",
keywords = "Chemotherapy, Cisplatin, OtoID, Ototoxicity, Tele-audiology, Telehealth, Veterans",
author = "Dille, {Marilyn F.} and McMillan, {Garnett P.} and Helt, {Wendy J.} and Dawn Konrad-Martin and Peter Jacobs",
year = "2015",
month = "10",
day = "1",
doi = "10.3766/jaaa.15028",
language = "English (US)",
volume = "26",
pages = "750--760",
journal = "Journal of the American Academy of Audiology",
issn = "1050-0545",
publisher = "American Academy of Audiology",
number = "9",

}

TY - JOUR

T1 - A store-and-forward tele-audiology solution to promote efficient screenings for ototoxicity during cisplatin cancer treatment

AU - Dille, Marilyn F.

AU - McMillan, Garnett P.

AU - Helt, Wendy J.

AU - Konrad-Martin, Dawn

AU - Jacobs, Peter

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Tele-audiology improves access, controls cost, and improves efficiency ofmany aspects within health care. We have developed and validated a device, the ototoxicity identification device (OtoID), which enables remote hearing monitoring by a patient during chemotherapy treatment. Aspects of the design such as patient self-testing and texting of results to the audiology clinic are important features of this device. Purpose: The purpose of this article is to present the efficacy and effectiveness of the OtoID hearing screener. Research Design: A repeated measures design was used in this study. Study Sample: Twenty-one veterans undergoing cisplatin chemotherapy were recruited in this study. Data Collection and Analysis: Participants were tested using the OtoID at each cisplatin treatment by an audiologist using the manual mode of test and the participant using the automated mode of test. Test sensitivity and specificity were developed from the detection (yes/no) of an American Speech-Language-Hearing Association (ASHA) change in hearing. Results: The OtoID had a test sensitivity of 80.6% and specificity of 85.3%. A logistic regression model analysis of the probability of an ASHA shift identified by the automated OtoID was conducted. Separatemodelswere fit to establish effects of age, average baseline thresholds in the sensitive range for ototoxicity (SRO), and dose of cisplatin on the probability of a positive hearing change result. Interactions were also included to evaluate these effects on the sensitivity and false-positive rates of the automated test. Results indicated no statistically significant effects of age, of baseline hearing in the SRO frequencies, or of cisplatin dose. Conclusions: The OtoID automated test can be recommended for use. The automated test provides significant personnel efficiencies. The modem with simple text messaging function recently added to the device improves on these efficiencies.

AB - Background: Tele-audiology improves access, controls cost, and improves efficiency ofmany aspects within health care. We have developed and validated a device, the ototoxicity identification device (OtoID), which enables remote hearing monitoring by a patient during chemotherapy treatment. Aspects of the design such as patient self-testing and texting of results to the audiology clinic are important features of this device. Purpose: The purpose of this article is to present the efficacy and effectiveness of the OtoID hearing screener. Research Design: A repeated measures design was used in this study. Study Sample: Twenty-one veterans undergoing cisplatin chemotherapy were recruited in this study. Data Collection and Analysis: Participants were tested using the OtoID at each cisplatin treatment by an audiologist using the manual mode of test and the participant using the automated mode of test. Test sensitivity and specificity were developed from the detection (yes/no) of an American Speech-Language-Hearing Association (ASHA) change in hearing. Results: The OtoID had a test sensitivity of 80.6% and specificity of 85.3%. A logistic regression model analysis of the probability of an ASHA shift identified by the automated OtoID was conducted. Separatemodelswere fit to establish effects of age, average baseline thresholds in the sensitive range for ototoxicity (SRO), and dose of cisplatin on the probability of a positive hearing change result. Interactions were also included to evaluate these effects on the sensitivity and false-positive rates of the automated test. Results indicated no statistically significant effects of age, of baseline hearing in the SRO frequencies, or of cisplatin dose. Conclusions: The OtoID automated test can be recommended for use. The automated test provides significant personnel efficiencies. The modem with simple text messaging function recently added to the device improves on these efficiencies.

KW - Chemotherapy

KW - Cisplatin

KW - OtoID

KW - Ototoxicity

KW - Tele-audiology

KW - Telehealth

KW - Veterans

UR - http://www.scopus.com/inward/record.url?scp=84943227076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943227076&partnerID=8YFLogxK

U2 - 10.3766/jaaa.15028

DO - 10.3766/jaaa.15028

M3 - Article

C2 - 26415968

AN - SCOPUS:84943227076

VL - 26

SP - 750

EP - 760

JO - Journal of the American Academy of Audiology

JF - Journal of the American Academy of Audiology

SN - 1050-0545

IS - 9

ER -